Isoflavones and soy protein formulas
Cantani, A.
European Review for Medical and Pharmacological Sciences 2(2): 97-98
1998
ISSN/ISBN: 1128-3602 PMID: 10229565 Document Number: 488738
A concern has arisen about the possible untoward effects in atopic children of isoflavones present in soy-protein-formulas. However, the studies as yet available fail to support these concerns.
Document emailed within 1 workday
Related Documents
Shahbazian, H.; Reza, A.; Javad, S.; Heshmatollah, S.; Mahmood, L.; Ali, A.; Hosain, H.M. 2007: Beneficial effects of soy protein isoflavones on lipid and blood glucose concentrations in type 2 diabetic subjects Saudi Medical Journal 28(4): 652-654Mitchell, G.V.; Jenkins, M.Y. 1985: Assessment of protein quality methodology for infant formulas Journal - Association of Official Analytical Chemists 68(4): 680-683
Fanaro, S.; Vigi, V. 2002: Protein quality and quantity in infant formulas. A critical look Minerva Pediatrica 54(3): 203-209
Räihä, N.C. 1985: Protein quality in feeding the normal infant: do whey-predominant formulas offer nutritional advantages? Pediatrics 76(2): 329
Räihä, N.C. 1985: Protein quality in feeding the normal infant: do whey-predominant formulas offer nutritional advantages? Pediatrics 76(2): 329
Tamm, C. 1972: Homo-isoflavones, a new series of natural products Arzneimittel-Forschung 22(10): 1776-1784
Gong, T.; Wang, H.-Q.; Chen, R.-Y. 2007: Isoflavones from vine stem of Millettia dielsiana Zhongguo Zhong Yao Za Zhi 32(20): 2138-2140
Rolfe, B.G. 1988: Flavones and isoflavones as inducing substances of legume nodulation Biofactors 1(1): 3-10
Kim, M.H.; Gutierrez, A.M.; Goldfarb, R.H. 2002: Different mechanisms of soy isoflavones in cell cycle regulation and inhibition of invasion Anticancer Research 22(6c): 3811-3817
Hale, G.E.; Hughes, C.L.; Cline, J.M. 2002: Endometrial cancer: hormonal factors, the perimenopausal "window of risk," and isoflavones Journal of Clinical Endocrinology and Metabolism 87(1): 3-15
Yan, X.; Gu, J.; Sun, C.; Liu, D. 2001: Inhibition effect of soybean isoflavones on the oxidative modification of low-density lipoprotein Wei Sheng Yan Jiu 30(6): 346-349
Shirataki, Y.; Tani, S.; Sakagami, H.; Satoh, K.; Nakashima, H.; Gotoh, K.; Motohashi, N. 2001: Relationship between cytotoxic activity and radical intensity of isoflavones from Sophora species Anticancer Research 21(4a): 2643-2648
Srisomboon, Y.; Poonyachoti, S.; Deachapunya, C. 2016: Enhanced Secretion of Beta-Defensins in Endometrial Tissues and Epithelial Cells by Soy Isoflavones Journal of the Medical Association of Thailand 99 Suppl. 8: S142-S149
Foth, D.; Cline, J.M.; Römer, T. 2000: Effect of isoflavones on mammary gland and endometrium of postmenopausal macaques (Macaca fascicularis) Zentralblatt für Gynakologie 122(2): 96-102
Jing, Y.; Waxman, S. 1995: Structural requirements for differentiation-induction and growth-inhibition of mouse erythroleukemia cells by isoflavones Anticancer Research 15(4): 1147-1152
Krenn, L.; Pötsch, V. 2006: An efficient HPLC method for the quantification of isoflavones in soy extracts and soy dietary supplements in routine quality control Die Pharmazie 61(7): 582-585
Zhang, Y.-h.; Pang, H.-y.; Xiao, X.-h.; Wen, H.-x.; Ni, J. 2011: Effects of soy isoflavones and major active component genistein on the expression of ovarian estrogen receptor-α in rats Zhonghua Yi Xue Za Zhi 91(28): 1987-1991
Sorokin, P. 2011: L-carnitine in infant formulas Voprosy Pitaniia 80(6): 82-83
MacStravic, S. 2001: Need new beds? Throw out your old formulas Health Care Strategic Management 19(10): 1; 17-19
Coste, J.ël.; Bertagna, X.; Zureik, M.; Nicolas, P.; Ramez, P.; Hill, C.; Schlumberger, M. 2019: Are the two formulas of Levothyrox bioequivalent? La Revue du Praticien 69(8): 831-837